Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes

Benzinga2022-09-09

Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • lcw5257
    2022-09-11
    lcw5257
    Sure  to buy 
  • Bspn
    2022-09-09
    Bspn
    Ok
  • 来人
    2022-09-09
    来人
    Ok
  • GggSlimeR
    2022-09-09
    GggSlimeR
    Hi Thanks & Do not like my comment 
  • Kian009
    2022-09-09
    Kian009
    Nice
  • Footixx
    2022-09-09
    Footixx
    👍
Leave a comment
6